Aoxing Pharmaceutical Company Inc.
AXN
AXN was delisted on the 16th of October, 2017.
4 hedge funds and large institutions have $28K invested in Aoxing Pharmaceutical Company Inc. in 2014 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
75% more capital invested
Capital invested by funds: $16K → $28K (+$12K)
33% more funds holding
Funds holding: 3 → 4 (+1)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
+$4.48K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.69K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$6.81K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $14K | -$6.81K | -19,079 | -36% |
|
|
EWM
2
Evercore Wealth Management
New York
| $5K | – | – | – |
|
|
VKH
3
Virtu KCG Holdings
New York
| $5K | +$4.48K | +12,553 | New |
|
|
4
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $4K | +$3.69K | +10,328 | New |
|
AXN Hedge Fund Activity: Q1 2014 in Review
4 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Aoxing Pharmaceutical Company Inc. (AXN) for Q1 2014, worth a combined $28K — up 75% from $16K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new AXN positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Virtu KCG Holdings, opening a new position worth an estimated $4.48K. The largest seller was Citadel Advisors, cutting an estimated $6.81K.
- 4 institutional investors held Aoxing Pharmaceutical Company Inc. (AXN) as of Q1 2014, up from 3 in Q4 2013.
- Funds reported $28K of Aoxing Pharmaceutical Company Inc. stock for Q1 2014, up 75% quarter-over-quarter.
- 2 funds opened new Aoxing Pharmaceutical Company Inc. positions in Q1 2014 and 1 closed out, a net change of +1 holder.
- The largest Aoxing Pharmaceutical Company Inc. buyer in Q1 2014 was Virtu KCG Holdings, an estimated $4.48K added.
- The largest Aoxing Pharmaceutical Company Inc. seller in Q1 2014 was Citadel Advisors, an estimated $6.81K sold.
Based on aggregated 13F filings for Q1 2014.